SCHEMBL4032318

SCHEMBL4032318

CC1(C)CCc2[nH]c3ccc(C#N)cc3c2C1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AR P10275 3/20 0.55
MAPK10 P53779 1/20 0.43
RIPK1 Q13546 1/20 0.43
GSK3B P49841 8/20 0.43
CDK5 Q00535 8/20 0.43
CDK5R1 Q15078 8/20 0.43
GSK3A P49840 4/20 0.43
MAPT P10636 1/20 0.42
CCNB2 O95067 5/20 0.41
CDK1 P06493 5/20 0.41
CCNB1 P14635 5/20 0.41
CCNB3 Q8WWL7 5/20 0.41
CCNA2 P20248 2/20 0.41
CDK2 P24941 2/20 0.41
CCNA1 P78396 2/20 0.41
RORC P51449 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
PARP1 P09874 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9148539 0.89 AR (0.43) ARMAPK10RIPK1MAPT
SCHEMBL20602364 0.79 MAPT (0.59) GSK3BCDK5CDK5R1GSK3AMAPT
SCHEMBL4026285 0.79 BAZ2B (0.49) MAPK10MAPTMEN1KMT2A
SCHEMBL17026942 0.78 KDM4E (0.49) MAPTL3MBTL1MEN1KMT2ACFTR
SCHEMBL4032070 0.77 RORC (0.57) ARMAPK10RIPK1GSK3BCDK5
SCHEMBL541264 0.77 MAPT (0.59) ARMAPK10RIPK1GSK3BCDK5
SCHEMBL4024352 0.77 HSD17B10 (0.56) MAPTMEN1KMT2A
SCHEMBL17026844 0.76 KIF11 (0.46) GSK3BCDK5CDK5R1GSK3ACCNB2
SCHEMBL31510880 0.75 HTR2A (0.51) MAPTMEN1KMT2A
SCHEMBL31510878 0.75 HTR2A (0.51) MAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009103022-A1 DERIVATIVES OF SUBSTITUTED FUSED RING CYCLOINDOLES AND METHODS OF THEIR USE ITHERX PHARMACEUTICALS, INC. (US) 2009-08-20 WO disclosed